Harold Barron
South San Francisco, CANPI 1467709204
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $691,242 of the $691,242 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, GSK.
$691,242in general payments, 2019–2025
Across 2 payments — averaging $345,621 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$691K
What the payments were for
- Speaking & faculty fees$691,242100%
General payments by program year
22
23
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 2 | $691,242 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.